Convergence Investment Partners LLC acquired a new position in Molina Healthcare, Inc. (NYSE:MOH) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 15,521 shares of the company’s stock, valued at approximately $1,190,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Zions Bancorporation bought a new stake in Molina Healthcare in the third quarter worth about $118,000. Riverhead Capital Management LLC lifted its stake in Molina Healthcare by 64.2% in the second quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock worth $170,000 after purchasing an additional 963 shares during the last quarter. Sabal Trust CO bought a new stake in Molina Healthcare in the third quarter worth about $206,000. Capstone Investment Advisors Netherlands B.V. bought a new stake in Molina Healthcare in the second quarter worth about $249,000. Finally, First Quadrant L P CA lifted its stake in Molina Healthcare by 1,030.6% in the third quarter. First Quadrant L P CA now owns 3,618 shares of the company’s stock worth $249,000 after purchasing an additional 3,298 shares during the last quarter.

Several analysts have issued reports on MOH shares. ValuEngine raised shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. Raymond James Financial reissued a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Zacks Investment Research raised shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. Jefferies Group raised their price objective on shares of Molina Healthcare from $64.00 to $74.00 and gave the stock a “hold” rating in a research note on Friday, November 3rd. Finally, BMO Capital Markets started coverage on shares of Molina Healthcare in a research note on Monday, October 16th. They issued a “market perform” rating and a $70.00 price objective for the company. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $70.86.

In related news, Director Garrey Carruthers sold 1,300 shares of the business’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $75.66, for a total value of $98,358.00. Following the completion of the transaction, the director now owns 7,016 shares of the company’s stock, valued at $530,830.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider William Dentino sold 67,500 shares of the business’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $77.15, for a total transaction of $5,207,625.00. The disclosure for this sale can be found here. Insiders have sold 700,452 shares of company stock valued at $53,463,251 in the last ninety days. Insiders own 6.20% of the company’s stock.

Shares of Molina Healthcare, Inc. (NYSE:MOH) opened at $93.77 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.29 and a current ratio of 1.29. Molina Healthcare, Inc. has a 12 month low of $42.56 and a 12 month high of $93.85. The firm has a market cap of $5,350.00, a P/E ratio of -17.79, a PEG ratio of 1.15 and a beta of 0.97.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The company had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $4.95 billion. During the same period in the prior year, the firm posted $0.85 EPS. The business’s revenue was up 10.7% on a year-over-year basis. sell-side analysts expect that Molina Healthcare, Inc. will post -3.88 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece of content was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/01/19/convergence-investment-partners-llc-acquires-shares-of-15521-molina-healthcare-inc-moh.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.